These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21639888)

  • 1. Client preferences and acceptability for medical abortion and MVA as early pregnancy termination method in northwest Ethiopia.
    Woldetsadik MA; Sendekie TY; White MT; Zegeye DT
    Reprod Health; 2011 Jun; 8():19. PubMed ID: 21639888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
    Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
    Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
    Jensen JT; Harvey SM; Beckman LJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
    Howie FL; Henshaw RC; Naji SA; Russell IT; Templeton AA
    Br J Obstet Gynaecol; 1997 Jul; 104(7):829-33. PubMed ID: 9236649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
    Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore.
    Tan YL; Singh K; Tan KH; Gosavi A; Koh D; Abbas D; Winikoff B
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():144-147. PubMed ID: 30179732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care.
    Slade P; Heke S; Fletcher J; Stewart P
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1288-95. PubMed ID: 9883920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.
    Fox MC; Creinin MD; Harwood B
    Contraception; 2002 Oct; 66(4):225-9. PubMed ID: 12413616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
    Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for surgical intervention of early medical abortion.
    Meaidi A; Friedrich S; Gerds TA; Lidegaard O
    Am J Obstet Gynecol; 2019 May; 220(5):478.e1-478.e15. PubMed ID: 30763542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
    Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
    Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-management of first trimester medical termination of pregnancy: a qualitative study of women's experiences.
    Purcell C; Cameron S; Lawton J; Glasier A; Harden J
    BJOG; 2017 Dec; 124(13):2001-2008. PubMed ID: 28421651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester abortion with mifepristone and vaginal misoprostol.
    Knudsen UB
    Contraception; 2001 May; 63(5):247-50. PubMed ID: 11448463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
    Henshaw R; Naji S; Russell I; Templeton A
    Acta Obstet Gynecol Scand; 1994 Nov; 73(10):812-8. PubMed ID: 7817735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and risk factors for repeat abortions after surgical compared with medical termination of pregnancy.
    Niinimäki M; Pouta A; Bloigu A; Gissler M; Hemminki E; Suhonen S; Heikinheimo O
    Obstet Gynecol; 2009 Apr; 113(4):845-852. PubMed ID: 19305329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical priming with misoprostol before manual vacuum aspiration versus electric vacuum aspiration for first-trimester surgical abortion.
    Mittal S; Sehgal R; Aggarwal S; Aruna J; Bahadur A; Kumar G
    Int J Gynaecol Obstet; 2011 Jan; 112(1):34-9. PubMed ID: 21112054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.